Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Patients with pituitary adenomas usually receive "stress dose" steroids in the peri-operative peroids. Though randomized controlled trials(RCT) have not been performed to assess the necessity of steroid coverage, there are several studies that explained the changes of adrenal function during peri-operative peroids. The aim of the present study is to investigate whether it is necessary to employ conventional peri-operative glucocorticoid replacement therapy to all the patients undergoing surgery. METHODS: We searched studies addressing peri-operative steroids coverage for pituitary adenomas in the Web of Science, Medline and the Cochrane Library. Then we extracted studies about peri-operative morning serum cortisol(MSC) levels, morbidity of early postoperative adrenal insufficiency, postoperative diabetes insipidus, relationships between MSC levels and adrenal integrity. We used RevMan Software to combine the results for meta-analysis. We used fixed-effects models for there was no significant heterogeneity existed. FINDINGS: There are 18 studies from 11 countries published between 1987 and 2013 including 1224 patients. The postoperative serum cortisol levels were significantly increased compared with the preoperative one in hypothalamic-pituitary-adrenal axis(HPAA) functions preserved patients(P<0.00001). The morbidity of early postoperative adrenal insufficiency ranged from 0.96% to 12.90%, with the overall morbidity of 5.55%(41/739). There was no significant differences of early postoperative diabetes insipidus between no supplementation patients and in supplementation patients(P=0.82). Conversely, there may be some disadvantages of high levels of cortisols such as high incidence of osteopenia and bone derangement and even the increased mortality rate. The patients with MSC levels of less than 60 nmol/l at 3 days after operation is considered as adrenal insufficient and more than 270 nmol/l as adrenal sufficient. To patients with MSC levels of 60-270 nmol/l, we need more clinical data to establish further cortisol supplementation criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A morning cortisol measurement might be useful even after intraoperative administration of dexamethasone (237).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [237]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ciric, I., Ragin, A., Baumgartner, C., & Pierce, D. (1997) · Neurosurgery · doi:10.1097/00006123-199702000-00001 · Cited by 1,029
Perioperative glucocorticoid coverage. A reassessment 42 years after emergence of a problem
Salem, M., Tainsh, R. E., Bromberg, J., Loriaux, D. L., & Chernow, B. (1994) · Annals of Surgery · doi:10.1097/00000658-199404000-00013 · Cited by 357 · cited 7×
“Patients undergoing TSS usually receive “stress dose” steroids whether the hypothalamicpituitary-adrenal axis(HPAA) is deficient or preserved during TSS[2].”
BackgroundInfluentialFilipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · cited 1×
“Other studies reported that high dose of cortisol replacement therapy was associated with unfavorable metabolic profile, higher intraocular pressure levels[27, 28].”
ResultValue of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
HÄGG, E., ASPLUND, K., & LITHNER, F. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00780.x · Cited by 233 · cited 2×
“Hagg 1987[10] ITT * * * * * 200 nmol/l random 94% 86% Hagg 1987[10] ITT * * * * * 300 nmol/l random 94% 67% Auchus 1997 [6] ITT 6–30 months 60 nmol/l day3 100% 100% 270 nmol/l day3 100% 94%”
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205 · cited 1×
“reported that high dose of cortisols were in direct proportion to high incidence of osteopenia and bone derangement[24, 25].”
BackgroundRagin, A., Baumgartner, C., Pierce, D., & Ciric, I. (1997) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70812-8 · Cited by 175
Adaptation during surgical stress. A reevaluation of the role of glucocorticoids.
Udelsman, R., Ramp, J., Gallucci, W. T., Gordon, A., Lipford, E., Norton, J. A., Loriaux, D. L., & Chrousos, G. P. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112443 · Cited by 164 · cited 1×
“concluded that there was no apparent advantage in supraphysiological glucocorticoid prophylaxis during surgical stress in primates[23].”
BackgroundInder, W. J., & Hunt, P. J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8547 · Cited by 113 · cited 1×
“Though randomized controlled trials(RCT) have not been performed to assess the necessity of steroid coverage[3], there are several studies on the changes of HPAA functions associated with pituitary surgery.”
BackgroundCourtney, C. H., McAllister, A. S., McCance, D. R., Bell, P. M., Hadden, D. R., Leslie, H., Sheridan, B., & Atkinson, A. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01106.x · Cited by 95
AUBRY, R. H., NANKIN, H. R., MOSES, A. M., & STREETEN, D. H. P. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-11-1481 · Cited by 94
Research works printed but not linked: 1
- RCL Page, 1994, Is routine steroid administration required for pituitary surgery?, J Endocrinol, 140, P167
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
National UK guidelines for the management of paediatric craniopharyngioma
Gan, H., Morillon, P., Albanese, A., Aquilina, K., Chandler, C., Chang, Y.-C., Drimtzias, E., Farndon, S. J., Jacques, T. S., Korbonits, M., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00162-6 · Cited by 65
“64 .”
Yoon, H., Lee, H., Kim, Y. H., Lim, Y., & Park, H. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.11.085 · Cited by 50
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“…and small clinical trials using this approach, it requires close monitoring of morning serum cortisol concentration in the postoperative period and, while several threshold values have been suggested to predict SAI in this context 72,78,85 , no clear consensus exists to guide this practice 74 .”
InfluentialSterl, K., Thompson, B., Goss, C. W., Dacey, R. G., Rich, K. M., Zipfel, G. J., Chicoine, M. R., Kim, A. H., & Silverstein, J. M. (2018) · Neurosurgery · doi:10.1093/neuros/nyy479 · Cited by 33
Metadata
- Authors
- Tohti, M., Li, J., Zhou, Y., Hu, Y., Yu, Z., & Ma, C.
- Affiliations
- Nanjing General Hospital of Nanjing Military Command (CN)
- Corresponding author
- Ma, Chiyuan
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-16
- Volume
- 10
- Issue
- 3
- Pages
- e0119621
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4361329
- OpenAlex
- W2014179356
- Cited by
- 49
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 9 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 2 · 2016: 2
- FWCI
- 0.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Natural Science Foundation of China (30801178)
- Nanjing University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- pituitary adenoma, stress dose steroids, adrenal insufficiency, postoperative diabetes insipidus, hypothalamic-pituitary-adrenal axis, pituitary surgery
- MeSH terms
- Adolescent, Adrenal Insufficiency, Adult, Aged, Aged, 80 and over, Female, Glucocorticoids, Humans, Hydrocortisone, Male, Middle Aged, Pituitary Neoplasms, Hormone Replacement Therapy, Young Adult, Perioperative Period
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis. https://app.cochat.ai/papers/10.1371/journal.pone.0119621
- The paper
- Tohti, M., Li, J., Zhou, Y., Hu, Y., Yu, Z., & Ma, C. (2015). Is Peri-Operative Steroid Replacement Therapy Necessary for the Pituitary Adenomas Treated with Surgery? A Systematic Review and Meta Analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0119621
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.